Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated

K Doi1, T Ikeda, H Itoh

  • 1Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Arteriosclerosis, Thrombosis, and Vascular Biology
|June 9, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of protracted suffocation death.

Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992
Same author

[CT diagnosis of diffuse lung disease].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study.

Liver·1992
Same author

Listeric septicemia with meningitis in a neonatal calf.

The Journal of veterinary medical science·1992
Same author

[Exercise therapy on the basis of anaerobic threshold (AT)].

Kokyu to junkan. Respiration & circulation·1992
Same author

[Molecular biology of the natriuretic peptide system].

Nihon rinsho. Japanese journal of clinical medicine·1992

C-type natriuretic peptide (CNP) inhibits vascular smooth muscle cell proliferation and promotes redifferentiation. Overexpression of CNP in injured arteries suppressed neointimal formation and enhanced endothelial cell regeneration.

Area of Science:

  • Vascular Biology
  • Molecular Cardiology
  • Regenerative Medicine

Background:

  • C-type natriuretic peptide (CNP) functions as a vascular-type natriuretic peptide.
  • Particulate guanylate cyclase-B is the specific receptor for CNP, predominantly expressed in smooth muscle cells (SMCs).

Purpose of the Study:

  • To investigate the effect of stimulating the cyclic guanosine monophosphate (cGMP) cascade in proliferating SMCs using CNP.
  • To evaluate CNP's role in vascular injury and neointimal formation.

Main Methods:

  • Adenovirus-mediated overexpression of rat CNP cDNA (Ad.CNP) in cultured SMCs and rabbit femoral arteries.
  • Analysis of cell cycle regulators (p21, p16), SMC differentiation markers (smooth muscle myosin heavy chain-2), and receptor expression (guanylate cyclase-A).

Related Experiment Videos

  • Assessment of neointimal formation and endothelial cell regeneration in vivo following balloon injury.

    • Main Results:

    • Ad.CNP treatment inhibited SMC proliferation at G(1) phase, increasing p21 and p16 expression.
    • CNP reinduced expression of smooth muscle myosin heavy chain-2 and guanylate cyclase-A in SMCs.
    • In vivo, CNP overexpression significantly suppressed neointimal formation, enhanced smooth muscle myosin heavy chain-2 expression, and promoted early endothelial cell regeneration.

    Conclusions:

    • Stimulating the cGMP cascade in dedifferentiated SMCs induces growth inhibition and redifferentiation.
    • CNP plays a protective role in vascular injury by suppressing neointimal hyperplasia and promoting repair.
    • CNP-mediated effects offer a potential therapeutic strategy for vascular diseases.